Clinical trial
CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
NCT02994654 is registered in ClinicalTrials.gov with Avita Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
- Lead sponsor
- Avita Medical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- September 30, 2018
- Enrollment
- 12 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.